| Dr William J Comai, DO | |
|
710 North Ave, Battle Creek, MI 49017-3258 | |
| (269) 969-6251 | |
| (269) 969-6283 |
| Full Name | Dr William J Comai |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 710 North Ave, Battle Creek, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780683565 | NPI | - | NPPES |
| 2930581 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101010248 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Lakes Caring | Jackson, MI | Home health agency |
| Oaklawn Hospital | Marshall, MI | Hospital |
| Borgess Medical Center | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ella E M Brown Charitable Circle | 1254228745 | 98 |
News Archive
Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how antibiotic resistance in bacteria arises.
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
Alzheimer's disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study.
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
› Verified 7 days ago
| Entity Name | Ella E M Brown Charitable Circle |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366591794 PECOS PAC ID: 1254228745 Enrollment ID: O20040616001008 |
News Archive
Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how antibiotic resistance in bacteria arises.
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
Alzheimer's disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study.
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
› Verified 7 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how antibiotic resistance in bacteria arises.
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
Alzheimer's disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study.
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William J Comai, DO 710 North Ave, Battle Creek, MI 49017-3258 Ph: (269) 969-6251 | Dr William J Comai, DO 710 North Ave, Battle Creek, MI 49017-3258 Ph: (269) 969-6251 |
News Archive
Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how antibiotic resistance in bacteria arises.
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
Alzheimer's disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study.
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
› Verified 7 days ago
Theodore C Yee, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 269-969-6251 Fax: 269-969-6283 | |
Kristin Tompkins Mizerik, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 North Avenue, Outpatient Center, Battle Creek, MI 49017 Phone: 855-618-2676 | |
John C Morgan, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 269-969-6251 Fax: 269-969-6283 | |
Dr. Daniel X Garcia, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2 Heritage Oak Ln, Battle Creek, MI 49015 Phone: 269-979-6360 Fax: 269-979-6380 | |
Dr. Phillip John Dabrowski, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 877-704-3133 | |
Mark Dean Russell, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Heritage Oak Ln, Battle Creek, MI 49015 Phone: 269-979-6360 Fax: 269-979-6380 |